Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
February 26, 2019 10:06 AM 3 min read

Cutera Announces Global Commercial Launch Of the excel V+® the Next Generation Laser Platform

by Globe Newswire
Follow

WASHINGTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- On the eve of the 2019 American Academy of Dermatology (AAD) Annual Conference, Cutera, Inc. (NASDAQ:CUTR), ("Cutera" or the "Company"), announces the launch of its best-in-class excel V+ laser platform.  The excel V+ is a technological advancement that includes 50% more power and treatment speed, optimized delivery systems and parameters for unparalleled precision in treating vascular lesions and pigmentation concerns.

The excel V+ represents a significant leap forward in the Company's current excel V laser platform, widely recognized among dermatologists for its engineering excellence as a best-in-class platform for the treatment of dermatologic issues such as rosacea, poikiloderma, leg veins, skin pigmentation and acne scars. The advancements of the excel V+ include:

  • Fully-integrated 532/+ 1064 nm wavelengths, with the addition of ‘Green Genesis' a micro-pulsed 532 nm procedure
  • 50% more power with the 532 nm wavelength
  • Large spot sizes up to 16 mm for 2X faster treatments
  • New ‘Dermastat' tracing handpiece to quickly treat small vascular and pigmented lesions on the face and body

Dr. E. Vic Ross, world-renowned dermatologist practicing at Scripps Clinic, San Diego, CA stated, "I am very pleased to have collaborated with Cutera's R&D team on the development of the excel V+.  The technological advancements of the new laser enhance an already best-in-class platform. The new capabilities will transform the experience of my patients. The advancement of the technology means I will be able to treat veins and vascular lesions and skin pigmentation more efficiently, precisely, and with improved results." 

Market data demonstrates a large demand for these vascular and pigmentation treatments:

  • 415M people suffer from rosacea1
  • 84% of the population have spider veins2
  • 40% of the population suffer from pigment concerns3
  • Skin rejuvenation ranks in the top 10 of non surgical aesthetic procedures4

"The American Acadamy of Dermatologist is the largest and most influential dermatology group in the US, and we are thrilled to once again choose the AAD's annual meeting to unveil the latest Cutera innovation.  The launch of the excel V+ marks another milestone for Cutera's goals in providing best-in-class aesthetics technology for providers worldwide. We are proud to be at the forefront of these innovations over the past twenty years, and will continue to develop clinical advancements in laser and light-based technology that provide the best in patient care," said Jason Richey, COO and Interim CEO of Cutera.

Cutera will also be conducting live demonstrations of its extremely popular body sculpting device, truSculpt iD at AAD.  The Company will also host twelve leading dermatologists in their AAD booth #1501, who will share valuable insights on the latest trends in aesthetics treatments and technology. 

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

  1. Rosacea.org
  2. https://www.everydayhealth.com/skin-and-beauty/what-causes-spider-veins.aspx
  3. https://www.alliedmarketresearch.com/tattoo-removal-market
  4. ASAPS 2017 Statistics

Cutera, Inc.
Tanya Rodante
Director, Marketing Communications
415-657-5500
[email protected]

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Press ReleasesGeneral
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

Comments
Loading...